Robert Zahler

3.4k citations

49 papers · 1.8k indexed · h-index 25

Co-authors: Gregory S. Bisacchi Richard J. Colonno Steven Innaimo Maria Seifer David N. Standring James M. Takacs David A. Evans Thomas L. Shih
Topics: HIV/AIDS drug development and treatment (10 papers)Synthesis and Catalytic Reactions (7 papers)Cytomegalovirus and herpesvirus research (7 papers)
Cited by: Hepatology Organic Chemistry Virology
Journals: Journal of the American Chemical Society Journal of Virology Journal of Medicinal Chemistry
Partner nations: United States Germany Sweden

In The Last Decade

Robert Zahler

49 papers receiving 1.8k citations

Peers

Countries citing papers authored by Robert Zahler

Since Specialization

Citations

This map shows the geographic impact of Robert Zahler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Zahler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Zahler more than expected).

Fields of papers citing papers by Robert Zahler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Zahler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Zahler. The network helps show where Robert Zahler may publish in the future.

Co-authorship network of co-authors of Robert Zahler

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Zahler. A scholar is included among the top collaborators of Robert Zahler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Zahler. Robert Zahler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bioanalysis of Pseudomonas aeruginosa alkyl quinolone signalling molecules in infected mouse tissue using LC–MS/MS; and its application to a pharmacodynamic evaluation of MvfR inhibition 2017 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown),(unknown),Patrick Barton,(unknown),Laurence G. Rahme,Michael J. Pucci,Robert Zahler,Aileen Rubio	14
2	Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold 2013 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),James Sutton,(unknown),Gregory S. Bisacchi,Bruce L. Jacobson,William A. Slusarchyk,(unknown),Shung Wu,Guohua Zhao,Zulan Pi,S. Sheriff,(unknown),(unknown),Daniel L. Cheney,Anzhi Wei,William A. Schumacher,Karen S. Hartl,(unknown),Robert Zahler,Steven M. Seiler	12
3	7-Oxopyrrolopyridine-derived DPP4 inhibitors—mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site 2011 ·Bioorganic & Medicinal Chemistry Letters ·Wei Wang,Pratik Devasthale,Aiying Wang,(unknown),(unknown),Nathan Morgan,Michael Cap,Aberra Fura,Herbert E. Klei,Kevin Kish,Carolyn A. Weigelt,Lucy Sun,Paul Lévesque,Yixin Li,Robert Zahler,Mark Kirby,Lawrence G. Hamann	15
4	Synthesis and SAR of azolopyrimidines as potent and selective dipeptidyl peptidase-4 (DPP4) inhibitors for type 2 diabetes 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Wei Meng,Aberra Fura,Thomas Harrity,Aiying Wang,Robert Zahler,Mark Kirby,Lawrence G. Hamann	47
5	Design, synthesis, and structure–activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARα/γ agonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Xiang‐Yang Ye,Yixin Li,Dennis Farrelly,Neil Flynn,Li‐Qun Gu,(unknown),Jonathan Lippy,Kevin O’Malley,(unknown),Litao Zhang,Denis E. Ryono,Robert Zahler,Narayanan Hariharan,Peter T. W. Cheng	6
6	Amino(methyl) pyrrolidines as novel scaffolds for factor Xa inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yan Shi,Doree Sitkoff,Jing Zhang,Wei Han,Zilun Hu,Philip D. Stein,Ying Wang,Lawrence J. Kennedy,Stephen P. O’Connor,(unknown),Eddie C.‐K. Liu,(unknown),Patrick Y. S. Lam,Jeffrey A. Robl,John E. Macor,Karnail S. Atwal,Robert Zahler	9
7	Synthesis and biological activity of 5-aryl-4-(4-(5-methyl-1H-imidazol-4-yl)piperidin-1-yl)pyrimidine analogs as potent, highly selective, and orally bioavailable NHE-1 inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Karnail S. Atwal,Steven V. O’Neil,Saleem Ahmad,(unknown),Mark Kirby,Charles R. Dorso,Gamini Chandrasena,Bang‐Chi Chen,Rui-Lin Zhao,Robert Zahler	33
8	Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase 2005 ·Bioorganic & Medicinal Chemistry Letters ·David S. Weinstein,Wen Liu,Zhengxiang Gu,Charles M. Langevine,Khehyong Ngu,(unknown),Donald W. Combs,Doree Sitkoff,(unknown),Shaobin Zhuang,Xing Chen,(unknown),Deborah A. Loughney,Karnail S. Atwal,Robert Zahler,John E. Macor,Cort S. Madsen,Natesan Murugesan	46
9	Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase 2004 ·Bioorganic & Medicinal Chemistry Letters ·Gregory S. Bisacchi,William A. Slusarchyk,(unknown),Karen S. Hartl,G. A. JACOBS,Arvind Mathur,Wei Meng,Martin L. Ogletree,Zulan Pi,James Sutton,(unknown),Robert Zahler,Guohua Zhao,Steven M. Seiler	27
10	Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors 2004 ·Bioorganic & Medicinal Chemistry Letters ·James Sutton,(unknown),Malcolm E. Davis,Karen S. Hartl,Bruce L. Jacobson,Arvind Mathur,Martin L. Ogletree,William A. Slusarchyk,Robert Zahler,Steven M. Seiler,Gregory S. Bisacchi	56
11	Synthesis of potent and highly selective inhibitors of human tryptase 2002 ·Bioorganic & Medicinal Chemistry Letters ·William A. Slusarchyk,(unknown),Karen S. Hartl,Ming‐Hsing Huang,G. A. JACOBS,Wei Meng,Martin L. Ogletree,Zulan Pi,William A. Schumacher,Steven M. Seiler,James Sutton,(unknown),Robert Zahler,Guohua Zhao,Gregory S. Bisacchi	41
12	Synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors 2002 ·Bioorganic & Medicinal Chemistry Letters ·James Sutton,(unknown),Karen S. Hartl,Ming‐Hsing Huang,G. A. JACOBS,Wei Meng,Martin L. Ogletree,Zulan Pi,William A. Schumacher,Steven M. Seiler,William A. Slusarchyk,(unknown),Robert Zahler,Guohua Zhao,Gregory S. Bisacchi	53
13	A practical method for the preparation of α′-chloroketones of N-carbamate protected-α-aminoacids 1997 ·Tetrahedron Letters ·(unknown),Peter T. W. Cheng,Steven H. Spergel,Robert Zahler,Xuebao Wang,John K. Thottathil,Joel C. Barrish,Richard P. Polniaszek	38
14	Phosphinyl Acid-Based Bisubstrate Analog Inhibitors of Farnesyl Protein Transferase 1995 ·Journal of Medicinal Chemistry ·Dinesh V. Patel,Eric M. Gordon,Robert J. Schmidt,Harold N. Weller,Mairead Young,Robert Zahler,Mariano Barbacid,Joan M. Carboni,Johnni Gullo-Brown,Lisa Hunihan,(unknown),(unknown),(unknown),(unknown),(unknown)	60
15	Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease 1995 ·Antimicrobial Agents and Chemotherapy ·Clifford Bechtold,Amy K. Patick,Masud Alam,(unknown),Joseph A. Tino,(unknown),Eric M. Gordon,Saleem Ahmad,Joel C. Barrish,Robert Zahler	12
16	Total synthesis of the polyether antibiotic ionomycin 1990 ·Journal of the American Chemical Society ·David A. Evans,Robert L. Dow,Thomas L. Shih,James M. Takacs,Robert Zahler	181
17	Synthesis of SQ-32,829, a new nucleoside antiviral agent 1989 ·Tetrahedron Letters ·G. A. JACOBS,Joseph A. Tino,Robert Zahler	40
18	Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG 1988 ·Antiviral Research ·Brian Terry,Kathryn Mazina,Anne V. Tuomari,M L Haffey,Moira Hagen,(unknown),William A. Slusarchyk,M. G. YOUNG,Robert Zahler,Anjalie Field	30
19	Enzyme Structure and Mechanism 1979 ·The Yale Journal of Biology and Medicine ·Robert Zahler	8
20	Structure of the Human Brain. 2nd edition 1977 ·The Yale Journal of Biology and Medicine ·Robert Zahler	2

About Robert Zahler

Robert Zahler is a scholar working on Virology, Organic Chemistry and Infectious Diseases, having authored 49 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (10 papers), Synthesis and Catalytic Reactions (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Hepatology (275 citations), Organic Chemistry (834 citations) and Virology (130 citations). Robert Zahler has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Gregory S. Bisacchi, Richard J. Colonno, Steven Innaimo, Maria Seifer, David N. Standring, James M. Takacs, David A. Evans, Thomas L. Shih, Robert L. Dow and G. A. JACOBS. Their work appears in journals such as Journal of the American Chemical Society, Journal of Virology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact